Mexico · Delayed Price · Currency is MXN Kodiak Sciences Statistics
Total Valuation
Kodiak Sciences has a market cap or net worth of MXN 22.75 billion. The enterprise value is 22.57 billion.
| Market Cap | 22.75B |
| Enterprise Value | 22.57B |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 52.93M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 5.51% |
| Owned by Institutions (%) | 46.31% |
| Float | 29.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 52.35 |
| P/TBV Ratio | 52.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.66 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.67 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 2.63.
| Current Ratio | 1.78 |
| Quick Ratio | 1.70 |
| Debt / Equity | 2.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.49 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -207.92% and return on invested capital (ROIC) is -80.91%.
| Return on Equity (ROE) | -207.92% |
| Return on Assets (ROA) | -47.21% |
| Return on Invested Capital (ROIC) | -80.91% |
| Return on Capital Employed (ROCE) | -127.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -32.41M |
| Employee Count | 109 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +187.25% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +187.25% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.09B |
| Pretax Income | -3.99B |
| Net Income | -3.99B |
| EBITDA | -3.75B |
| EBIT | -4.09B |
| Earnings Per Share (EPS) | -75.56 |
Balance Sheet
The company has 1.32 billion in cash and 1.14 billion in debt, giving a net cash position of 180.43 million.
| Cash & Cash Equivalents | 1.32B |
| Total Debt | 1.14B |
| Net Cash | 180.43M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 434.56M |
| Book Value Per Share | 8.22 |
| Working Capital | 610.78M |
Cash Flow
In the last 12 months, operating cash flow was -2.32 billion and capital expenditures -10.77 million, giving a free cash flow of -2.33 billion.
| Operating Cash Flow | -2.32B |
| Capital Expenditures | -10.77M |
| Free Cash Flow | -2.33B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Kodiak Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.42% |
| Shareholder Yield | -0.42% |
| Earnings Yield | -17.52% |
| FCF Yield | -10.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |